Related Experiment Video
Updated: Aug 8, 2026

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Establishment and characterization of new pre-B cell leukemia cell line NALM-26
Human Cell
|December 1, 1994
Abstract:
A new pre-B cell leukemia cell line, NALM-26, was established from the peripheral blood of a 24-year-old male patient with acute pre-B cell leukemia. NALM-26 is unique in its expression of T cell-associated CD5 and myeloid cell-associated CD13 antigens. Interleukin-7 (IL-7) receptor (CDw127) was detected by flow cytometric analysis. After PMA treatment, NALM-26 was induced to express CD20, CD25 and CD28, and to increase its expression of both CD5 and CD13. The expression of CDw127 was down-modulated.

